Cargando…

Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis

BACKGROUND: This study was designed to evaluate the population pharmacokinetics (popPK) of penicillin G in patients with infective endocarditis and establish a dosage regimen based on pharmacokinetic data and clinical outcome. METHOD: Forty-six serum penicillin G samples from 25 individuals were ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Komatsu, Toshiaki, Inomata, Takayuki, Watanabe, Ichiro, Kobayashi, Masahiro, Kokubun, Hideya, Ako, Junya, Atsuda, Koichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820900/
https://www.ncbi.nlm.nih.gov/pubmed/27051524
http://dx.doi.org/10.1186/s40780-016-0043-x
_version_ 1782425490594725888
author Komatsu, Toshiaki
Inomata, Takayuki
Watanabe, Ichiro
Kobayashi, Masahiro
Kokubun, Hideya
Ako, Junya
Atsuda, Koichiro
author_facet Komatsu, Toshiaki
Inomata, Takayuki
Watanabe, Ichiro
Kobayashi, Masahiro
Kokubun, Hideya
Ako, Junya
Atsuda, Koichiro
author_sort Komatsu, Toshiaki
collection PubMed
description BACKGROUND: This study was designed to evaluate the population pharmacokinetics (popPK) of penicillin G in patients with infective endocarditis and establish a dosage regimen based on pharmacokinetic data and clinical outcome. METHOD: Forty-six serum penicillin G samples from 25 individuals were analyzed using a nonlinear mixed-effects model. popPK were estimated using a one-compartment model. We created a receiver operating characteristic (ROC) curve for penicillin G efficacy and the ratio of its minimum concentration (Cmin)/minimum inhibitory concentration (MIC). Simulations were used to optimize the penicillin G dosage regimen using this ratio. RESULT: Estimated popPK were: CL (L/h) = 0.21 × creatinine clearance (CLcr) (mL/min), Vd (L) = 28.9. The areas under the ROC curves were 0.87 for clinical efficacy. The cut-off value of penicillin G Cmin/MIC was 60. The continuous administration of 1 million IU penicillin G/h was necessary to achieve a positive outcome for patients with normal renal function (CLcr ≥ 60 mL/min). CONCLUSION: Our findings suggest that population-based parameters are useful for evaluating penicillin G pharmacokinetics and that an individualized dosage should be determined based on a described dosage regimen.
format Online
Article
Text
id pubmed-4820900
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48209002016-04-06 Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis Komatsu, Toshiaki Inomata, Takayuki Watanabe, Ichiro Kobayashi, Masahiro Kokubun, Hideya Ako, Junya Atsuda, Koichiro J Pharm Health Care Sci Research Article BACKGROUND: This study was designed to evaluate the population pharmacokinetics (popPK) of penicillin G in patients with infective endocarditis and establish a dosage regimen based on pharmacokinetic data and clinical outcome. METHOD: Forty-six serum penicillin G samples from 25 individuals were analyzed using a nonlinear mixed-effects model. popPK were estimated using a one-compartment model. We created a receiver operating characteristic (ROC) curve for penicillin G efficacy and the ratio of its minimum concentration (Cmin)/minimum inhibitory concentration (MIC). Simulations were used to optimize the penicillin G dosage regimen using this ratio. RESULT: Estimated popPK were: CL (L/h) = 0.21 × creatinine clearance (CLcr) (mL/min), Vd (L) = 28.9. The areas under the ROC curves were 0.87 for clinical efficacy. The cut-off value of penicillin G Cmin/MIC was 60. The continuous administration of 1 million IU penicillin G/h was necessary to achieve a positive outcome for patients with normal renal function (CLcr ≥ 60 mL/min). CONCLUSION: Our findings suggest that population-based parameters are useful for evaluating penicillin G pharmacokinetics and that an individualized dosage should be determined based on a described dosage regimen. BioMed Central 2016-04-05 /pmc/articles/PMC4820900/ /pubmed/27051524 http://dx.doi.org/10.1186/s40780-016-0043-x Text en © Komatsu et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Komatsu, Toshiaki
Inomata, Takayuki
Watanabe, Ichiro
Kobayashi, Masahiro
Kokubun, Hideya
Ako, Junya
Atsuda, Koichiro
Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
title Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
title_full Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
title_fullStr Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
title_full_unstemmed Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
title_short Population pharmacokinetic analysis and dosing regimen optimization of penicillin G in patients with infective endocarditis
title_sort population pharmacokinetic analysis and dosing regimen optimization of penicillin g in patients with infective endocarditis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820900/
https://www.ncbi.nlm.nih.gov/pubmed/27051524
http://dx.doi.org/10.1186/s40780-016-0043-x
work_keys_str_mv AT komatsutoshiaki populationpharmacokineticanalysisanddosingregimenoptimizationofpenicillinginpatientswithinfectiveendocarditis
AT inomatatakayuki populationpharmacokineticanalysisanddosingregimenoptimizationofpenicillinginpatientswithinfectiveendocarditis
AT watanabeichiro populationpharmacokineticanalysisanddosingregimenoptimizationofpenicillinginpatientswithinfectiveendocarditis
AT kobayashimasahiro populationpharmacokineticanalysisanddosingregimenoptimizationofpenicillinginpatientswithinfectiveendocarditis
AT kokubunhideya populationpharmacokineticanalysisanddosingregimenoptimizationofpenicillinginpatientswithinfectiveendocarditis
AT akojunya populationpharmacokineticanalysisanddosingregimenoptimizationofpenicillinginpatientswithinfectiveendocarditis
AT atsudakoichiro populationpharmacokineticanalysisanddosingregimenoptimizationofpenicillinginpatientswithinfectiveendocarditis